General Information of the Protein
Protein ID
PT01215
Protein Name
C-C chemokine receptor type 3
Secondarily
Protein Name
Eosinophil eotaxin receptor
Gene Name
CCR3
Secondarily
Gene Name
CMKBR3
Sequence
MTTSLDTVETFGTTSYYDDVGLLCEKADTRALMAQFVPPLYSLVFTVGLLGNVVVVMILIKYRRLRIMTNIYLLNLAISDLLFLVTLPFWIHYVRGHNWVFGHGMCKLLSGFYHTGLYSEIFFIILLTIDRYLAIVHAVFALRARTVTFGVITSIVTWGLAVLAALPEFIFYETEELFEETLCSALYPEDTVYSWRHFHTLRMTIFCLVLPLLVMAICYTGIIKTLLRCPSKKKYKAIRLIFVIMAVFFIFWTPYNVAILLSSYQSILFGNDCERSKHLDLVMLVTEVIAYSHCCMNPVIYAFVGERFRKYLRHFFHRHLLMHLGRYIPFLPSEKLERTSSVSPSTAEPELSIVF
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
Chemokine receptor
>
CC chemokine receptor
Function
Receptor for C-C type chemokine. Binds and responds to a variety of chemokines, including CCL11, CCL26, CCL7, CCL13, RANTES(CCL5) and CCL15 (PubMed:7622448, PubMed:8642344, PubMed:8676064). Subsequently transduces a signal by increasing the intracellular calcium ions level (PubMed:8676064). In addition acts as a possible functional receptor for NARS1 (PubMed:30171954).
    Show/Hide
Uniprot ID
Primary ID:
P51677

Secondarily ID:
B3KVQ1
F5GWL6
Q15748
Q2YDB9
Q86WD2
Q8TDP6
Q9ULY8
    Show/Hide
Ensembl ID
ENSG00000183625
HGNC ID
HGNC:1604
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000795 , 300-19
Compound ID Compound Name Compound Formula
CP0090447
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxy-4-methylbenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O3
 1
1
IC50 = 0.98 nM
   TI
   LI
   LO
   TS
CP0102939
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C29H30FN3O3
 2
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
2
IC50 = 8.4 nM
   TI
   LI
   LO
   TS
CP0452198
2-[1-(1,3-Benzodioxol-5-ylcarbonyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C30H30FN3O4
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0492671
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(4-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O3
 1
1
IC50 = 1.8 nM
   TI
   LI
   LO
   TS
CP0398965
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxy-4-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O4
 1
1
IC50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0540187
2-[1-(3,4-Dimethoxybenzoyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C31H34FN3O4
 1
1
IC50 = 3.6 nM
   TI
   LI
   LO
   TS
CP0421459
2-(1-Benzoylpiperidin-4-ylidene)-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C29H30FN3O2
 1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0492672
2-[1-(2-Fluorobenzoyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C29H29F2N3O2
 1
1
IC50 = 4.8 nM
   TI
   LI
   LO
   TS
CP0404911
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-hydroxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C29H30FN3O3
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0404912
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O3
 1
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
CP0504827
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(4-hydroxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C29H30FN3O3
 1
1
IC50 = 5.1 nM
   TI
   LI
   LO
   TS
CP0398966
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(3-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O3
 1
1
IC50 = 5.8 nM
   TI
   LI
   LO
   TS
CP0452197
2-[1-(4-Fluoro-2-hydroxybenzoyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C29H29F2N3O3
 1
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
CP0506155
2-[1-(4-Chloro-2-hydroxybenzoyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C29H29ClFN3O3
 1
1
IC50 = 7.5 nM
   TI
   LI
   LO
   TS
CP0799907
2-(Azepan-1-ylcarbonyl)-N-{(3-exo)-8-[(6-fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}benzamide
   Show/Hide
C32H36FN3O2
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0504828
(R)-2-(1-(3-fluorobenzoyl)piperidin-4-ylidene)-N-(1-((6-fluoronaphthalen-2-yl)methyl)pyrrolidin-3-yl)acetamide
   Show/Hide
C29H29F2N3O2
 1
1
IC50 = 12 nM
   TI
   LI
   LO
   TS
CP0844223
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-3-(piperidin-1-ylcarbonyl)isonicotinamide
   Show/Hide
C30H33FN4O2
 1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
CP0506156
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxy-5-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O4
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0067400
Biphenyl-2-carboxylic acid [(1R,5R)-8-(6-fluoro-naphthalen-2-ylmethyl)-8-aza-bicyclo[3.2.1]oct-3-yl]-amide
   Show/Hide
C31H29FN2O
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0421458
2-[1-(4-Fluorobenzoyl)piperidin-4-ylidene]-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C29H29F2N3O2
 1
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
CP0666454
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-3-(piperidin-1-ylcarbonyl)isonicotinamide 1-oxide
   Show/Hide
C30H33FN4O3
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0828774
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(piperidin-1-ylcarbonyl)benzamide
   Show/Hide
C31H34FN3O2
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0681149
4-(8-((6-fluoronaphthalen-2-yl)methyl)-8-azabicyclo[3.2.1]octan-3-ylcarbamoyl)-3-(piperidine-1-carbonyl)pyridine 1-oxide
   Show/Hide
C30H33FN4O3
 1
1
IC50 = 23 nM
   TI
   LI
   LO
   TS
CP0746384
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-pyridin-3-ylbenzamide
   Show/Hide
C30H28FN3O
 1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0435153
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-2-phenylbenzamide
   Show/Hide
C29H27FN2O
 1
1
IC50 = 38 nM
   TI
   LI
   LO
   TS
CP0504001
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxy-3-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O4
 1
1
IC50 = 38 nM
   TI
   LI
   LO
   TS
CP0806516
N-Cyclohexyl-N'-{(3-exo)-8-[(6-fluoro-2-naphthyl)-methyl]-8-azabicyclo[3.2.1]oct-3-yl}-N-methylphthalamide
   Show/Hide
C33H38FN3O2
 1
1
IC50 = 44 nM
   TI
   LI
   LO
   TS
CP0480383
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-[1-(2-hydroxy-6-methoxybenzoyl)piperidin-4-ylidene]acetamide
   Show/Hide
C30H32FN3O4
 1
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
CP0799901
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-pyridin-2-ylbenzamide
   Show/Hide
C30H28FN3O
 1
1
IC50 = 57 nM
   TI
   LI
   LO
   TS
CP0806517
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-4-(piperidin-1-ylcarbonyl)nicotinamide
   Show/Hide
C30H33FN4O2
 1
1
IC50 = 85 nM
   TI
   LI
   LO
   TS
CP0677445
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(1,3-thiazol-2-yl)benzamide
   Show/Hide
C28H26FN3OS
 1
1
IC50 = 89 nM
   TI
   LI
   LO
   TS
CP0828771
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-pyrimidin-5-ylbenzamidefumarate
   Show/Hide
C33H31FN4O5
 1
1
IC50 = 93 nM
   TI
   LI
   LO
   TS
CP0464185
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-2-phenoxybenzamide
   Show/Hide
C29H27FN2O2
 1
1
IC50 = 95 nM
   TI
   LI
   LO
   TS
CP0787219
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(piperidin-1-ylcarbonyl)nicotinamide
   Show/Hide
C30H33FN4O2
 1
1
IC50 = 98 nM
   TI
   LI
   LO
   TS
CP0421460
(2E)-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}-3-phenylacrylamide
   Show/Hide
C24H23FN2O
 1
1
IC50 = 100 nM
   TI
   LI
   LO
   TS
CP0646105
2-(Cyclohexyloxy)-N-{(3-exo)-8-[(6-fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}benzamide
   Show/Hide
C31H35FN2O2
 1
1
IC50 = 118 nM
   TI
   LI
   LO
   TS
CP0755468
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-3-(piperidin-1-ylcarbonyl)pyridine-2-carboxamide
   Show/Hide
C30H33FN4O2
 1
1
IC50 = 131 nM
   TI
   LI
   LO
   TS
CP0404913
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-phenylbenzamide
   Show/Hide
C28H25FN2O
 1
1
IC50 = 140 nM
   TI
   LI
   LO
   TS
CP0430815
2-(1-Acetylpiperidin-4-ylidene)-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acetamide
   Show/Hide
C24H28FN3O2
 1
1
IC50 = 160 nM
   TI
   LI
   LO
   TS
CP0398969
N-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-phenylacetamide
   Show/Hide
C23H23FN2O
 1
1
IC50 = 170 nM
   TI
   LI
   LO
   TS
CP0904404
N-{(3R)-1-[(6-Fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}-2-(4-phenoxycyclohexylidene)acetamide
   Show/Hide
C29H31FN2O2
 1
1
IC50 = 210 nM
   TI
   LI
   LO
   TS
CP0785159
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(1H-imidazol-1-yl)benzamide
   Show/Hide
C28H27FN4O
 1
1
IC50 = 217 nM
   TI
   LI
   LO
   TS
CP0828772
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(1H-pyrrol-1-yl)benzamide
   Show/Hide
C29H28FN3O
 1
1
IC50 = 221 nM
   TI
   LI
   LO
   TS
CP0716643
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(pyrrolidin-1-ylcarbonyl)benzamide
   Show/Hide
C30H32FN3O2
 1
1
IC50 = 225 nM
   TI
   LI
   LO
   TS
CP0492673
4-Fluoro-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]-pyrrolidin-3-yl}benzamide
   Show/Hide
C22H20F2N2O
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0430816
1-(benzenesulfonyl)-3-[(3R)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]urea
   Show/Hide
C22H22FN3O3S
 1
1
IC50 = 250 nM
   TI
   LI
   LO
   TS
CP0828773
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-piperidin-1-ylbenzamide
   Show/Hide
C30H34FN3O
 1
1
IC50 = 279 nM
   TI
   LI
   LO
   TS
CP0456034
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-2-phenylacetamide
   Show/Hide
C24H25FN2O
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0492674
[1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-(2-phenylphenyl)methanone
   Show/Hide
C28H24FNO
 1
1
IC50 = 320 nM
   TI
   LI
   LO
   TS
CP0772632
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-[(4-methylpiperazin-1-yl)carbonyl]benzamide
   Show/Hide
C31H35FN4O2
 1
1
IC50 = 482 nM
   TI
   LI
   LO
   TS
CP0404914
(rac)-N-{1-[(6-Fluoro-2-naphthyl)methyl]piperidin-3-yl}-biphenyl-2-carboxamide
   Show/Hide
C29H27FN2O
 1
1
IC50 = 550 nM
   TI
   LI
   LO
   TS
CP0435155
N-benzyl-1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-amine
   Show/Hide
C23H25FN2
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0787218
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-pyridin-4-ylbenzamide
   Show/Hide
C30H28FN3O
 1
1
IC50 = 613 nM
   TI
   LI
   LO
   TS
CP0490535
4-fluoro-N-(1-((6-fluoronaphthalen-2-yl)methyl)piperidin-4-yl)benzamide
   Show/Hide
C23H22F2N2O
 1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0435154
3-fluoro-N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]benzamide
   Show/Hide
C23H22F2N2O
 1
1
IC50 = 670 nM
   TI
   LI
   LO
   TS
CP0844222
N-{(3-exo)-8-[(6-Fluoro-2-naphthyl)methyl]-8-azabicyclo[3.2.1]oct-3-yl}-2-(morpholin-4-ylcarbonyl)benzamide
   Show/Hide
C30H32FN3O3
 1
1
IC50 = 679 nM
   TI
   LI
   LO
   TS
CP0371933
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-2-methoxybenzamide
   Show/Hide
C24H25FN2O2
 1
1
IC50 = 720 nM
   TI
   LI
   LO
   TS
CP0490537
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-N-methylbenzamide
   Show/Hide
C24H25FN2O
 1
1
IC50 = 810 nM
   TI
   LI
   LO
   TS
CP0490539
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]benzenesulfonamide
   Show/Hide
C22H23FN2O2S
 1
1
IC50 = 830 nM
   TI
   LI
   LO
   TS
CP0540188
(2E)-3-(1-Benzoylpiperidin-4-yl)-N-{(3R)-1-[(6-fluoro-2-naphthyl)methyl]pyrrolidin-3-yl}acrylamide
   Show/Hide
C30H32FN3O2
 1
1
IC50 = 900 nM
   TI
   LI
   LO
   TS
CP0513670
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-3-phenoxybenzamide
   Show/Hide
C29H27FN2O2
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0283763
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]benzamide
   Show/Hide
C23H23FN2O
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0551862
1-[(6-fluoronaphthalen-2-yl)methyl]-N-phenylpiperidine-4-carboxamide
   Show/Hide
C23H23FN2O
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0504829
1-(benzenesulfonyl)-3-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]urea
   Show/Hide
C23H24FN3O3S
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0505194
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-4-methoxybenzamide
   Show/Hide
C24H25FN2O2
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0514124
N-[(3S)-1-[(6-fluoronaphthalen-2-yl)methyl]pyrrolidin-3-yl]-2-phenylbenzamide
   Show/Hide
C28H25FN2O
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0454043
N-[1-[(6-fluoronaphthalen-2-yl)methyl]-4-methylpiperidin-4-yl]-2-phenylbenzamide
   Show/Hide
C30H29FN2O
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0513671
2-fluoro-N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]benzamide
   Show/Hide
C23H22F2N2O
 1
1
IC50 = 2900 nM
   TI
   LI
   LO
   TS
CP0458537
N-[1-[(E)-3-(4-fluorophenyl)prop-2-enyl]piperidin-4-yl]benzamide
   Show/Hide
C21H23FN2O
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0458359
N-[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl]-3-methoxybenzamide
   Show/Hide
C24H25FN2O2
 1
1
IC50 = 3500 nM
   TI
   LI
   LO
   TS
CP0510759
[1-[(6-fluoronaphthalen-2-yl)methyl]piperidin-4-yl] N-phenylcarbamate
   Show/Hide
C23H23FN2O2
 1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0398968
(2E)-N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}-3-phenylacrylamide
   Show/Hide
C25H25FN2O
 1
1
IC50 = 9700 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0094763
1-((2R,3S)-4-((S)-3-(4-fluorobenzyl)piperidin-1-yl)-3-hydroxybutan-2-yl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)urea
   Show/Hide
C25H32FN7O2
 1
1 IC50 = 0.3 nM
CP0036478
1-((1R,2S)-2-(((S)-3-(4-fluorobenzyl)piperidin-1-yl)methyl)cyclohexyl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)urea
   Show/Hide
C28H36FN7O
 2
1 IC50 = 0.5 nM
2 IC50 = 2 nM
CP0059520
1-((1R,2S)-2-(((S)-3-(4-fluorobenzyl)piperidin-1-yl)methyl)cyclohexyl)-3-(5-acetyl-4-methylthiazol-2-yl)urea
   Show/Hide
C26H35FN4O2S
 1
1 IC50 = 0.5 nM
CP0131315
1-((E)-1-Cyclooct-1-enyl)methyl-4-[(2,7-dichloro-9H-xanthene-9-carbonyl)-amino]-1-ethyl-piperidinium; iodide
   Show/Hide
C30H37Cl2IN2O2
 1
1 IC50 = 0.58 nM
CP0263957
1-(3-((S)-3-(4-fluorobenzyl)piperidin-1-yl)propyl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenyl)urea
   Show/Hide
C24H30FN7O
 1
1 IC50 = 0.6 nM
CP0035037
1-((1R,2S)-2-(((S)-3-(4-fluorobenzyl)piperidin-1-yl)methyl)cyclohexyl)-3-(3-acetylphenyl)urea
   Show/Hide
C28H36FN3O2
 2
1 IC50 = 0.8 nM
2 IC50 = 2 nM
CP0243337
(S)-1-(3-(3-(4-fluorobenzyl)piperidin-1-yl)propyl)-3-(3,5-diacetylphenyl)urea
   Show/Hide
C26H32FN3O3
 1
1 IC50 = 1.2 nM
CP0294093
1-((3S,4S)-4-(((S)-3-(4-fluorobenzyl)piperidin-1-yl)methyl)-1-methylpiperidin-3-yl)-3-(5-acetyl-4-methylthiazol-2-yl)urea
   Show/Hide
C26H36FN5O2S
 1
1 IC50 = 1.2 nM
CP0113627
1-(3-((S)-3-(4-fluorobenzyl)piperidin-1-yl)propyl)-3-(3-methyl-5-(1-methyl-1H-tetrazol-5-yl)phenyl)urea
   Show/Hide
C25H32FN7O
 1
1 IC50 = 1.5 nM
CP0228253
2-(6-Amino-benzothiazol-2-ylsulfanyl)-N-[1-(3,4-dichloro-benzyl)-piperidin-4-yl]-acetamide
   Show/Hide
C21H22Cl2N4OS2
 1
1 IC50 = 2.3 nM
CP0049932
(S)-1-(3-(3-(4-fluorobenzyl)piperidin-1-yl)propyl)-3-(3-acetylphenyl)urea
   Show/Hide
C24H30FN3O2
 1
1 IC50 = 2.5 nM
CP0307123
1-(3-((S)-3-(4-fluorobenzyl)piperidin-1-yl)propyl)-3-(3-acetyl-5-(1-methyl-1H-tetrazol-5-yl)phenyl)urea
   Show/Hide
C26H32FN7O2
 1
1 IC50 = 2.6 nM
CP0183536
(S)-2-[(Naphthalene-1-carbonyl)-amino]-3-(4-nitro-phenyl)-propionic acid methyl ester
   Show/Hide
C21H18N2O5
 2
1 IC50 = 5 nM
2 IC50 = 7 nM
CP0270497
4-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-N-(4-methylphenyl)sulfonylpiperidine-1-carboxamide
   Show/Hide
C24H29Cl2N3O4S
 1
1 IC50 = 8.1 nM
CP0194068
1-(3-Acetyl-phenyl)-3-{3-[4-(4-fluoro-benzyl)-piperidin-1-yl]-propyl}-urea
   Show/Hide
C24H30FN3O2
 1
1 IC50 = 10 nM
CP0085008
2-(Benzothiazol-2-ylsulfanyl)-N-[1-(3,4-dichloro-benzyl)-piperidin-4-yl]-acetamide
   Show/Hide
C21H21Cl2N3OS2
 1
1 IC50 = 32 nM
CP0086677
6-[2-ethyl-6-fluoro-3-[1-[3-(4-fluorophenyl)sulfanylpropyl]piperidin-4-yl]indol-1-yl]pyridine-3-carboxylic acid
   Show/Hide
C30H31F2N3O2S
 2
1 IC50 = 40 nM
2 IC50 = 531.8 nM
Clinical Information about the Protein
Target 1 ( CCR3 messenger RNA (CCR3 mRNA) )
Target Type Clinical trial Target
Target 2 ( C-C chemokine receptor type 3 (CCR3) )
Target Type Discontinued Target
Disease 1 Target-related Disease  1
1 Parkinson disease [ICD-11: 8A00.0]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 AKST4290 Phase 2
Parkinson disease